Navigation Links
JHP Pharmaceuticals Enters Agreement to Produce Diagnostic Aid
Date:10/18/2011

PARSIPPANY, N.J., Oct. 18, 2011 /PRNewswire/ -- JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile injectable products announced today that it has entered into an agreement with an undisclosed pharmaceutical company for the product transfer and registration batch production of a diagnostic aid.

Stuart Hinchen, president and CEO of JHP stated "Our record of cGMP compliance, coupled with comprehensive experience in manufacturing site transfers put us in the position to serve this important customer."

Commenting on the successful completion of recent FDA and EMA audits in addition to agreements with six new customers, Hinchen noted, "Our Rochester, Michigan site has a 25 year history in contract manufacturing. This accomplishment was created by a quality-driven, experienced staff and a customer-centric approach. Since purchasing the plant in 2007, we have focused on growing our internal infrastructure to support expansion of our contract manufacturing services by investing in both our people and our facilities. Recent investments include a clinical filler and a 240 sq. ft. lyophilizer in addition to expanding our Manufacturing, Regulatory and Quality Teams."

"JHP Pharmaceuticals has extensive experience working with products throughout their life cycle starting with clinical trial supplies, through regulatory approval, product launch and global commercialization providing customers with the right scale and experience to meet their product life cycle needs."

About JHP Pharmaceuticals, LLC

JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables, biologics, vaccines, ophthalmics and otics for large and small pharmaceutical and biotech organizations. JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, four lyophilizers and a clinical fill line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, regulatory, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.

Contact:
Dan Leone
973.658.3559

Bill Conway
877.906.7556

jhpcontractservices@jhppharma.com

MK265


'/>"/>
SOURCE JHP Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Par Pharmaceutical Acquires Three Generic Products From Teva Pharmaceuticals
2. Ampio Pharmaceuticals Announces a Proof of Concept Trial of Danazol in the Treatment of Allergic Rhinitis Supports Mechanism of Action of Optina™
3. Pacira Pharmaceuticals, Inc. Announces Key EXPAREL™ Data to be Presented at American College of Surgeons 97th Annual Clinical Congress
4. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG
5. Auxilium Pharmaceuticals to Announce Third Quarter 2011 Results and Conduct Conference Call on Monday, October 31, 2011
6. Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors
7. Access Pharmaceuticals Updates MuGard Website with New Video Featuring Clinical Feedback and Manufacturing Footage
8. Cumberland Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 3, 2011
9. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
10. Amylin Pharmaceuticals to Webcast Third Quarter Results
11. Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Transparency Market Research has ... Insufficiency Market - Global Industry Analysis, Size, Share, Growth, ... the report, the exocrine pancreatic insufficiency market is anticipated ... to 2023 to reach US$2.85 Bn by 2023. ... by the deficiency of the exocrine pancreatic enzymes, causing ...
(Date:5/23/2016)... , May 23, 2016 ... Devices, Diagnostics and Monitoring, and Vision Care ... Which areas are going to grow at the fastest ... revenues to 2026, assessing data, trends, opportunities and prospects. ... charts, and graphs. Discover the most lucrative areas in ...
(Date:5/23/2016)... 2016 Non-invasive diagnostic test realizes ... diseases; ,Technology to be presented at Yissum’s booth, at ... Development Company of the Hebrew University of Jerusalem ... with Aurum Ventures MKI, the technology investment arm of ... diagnostic approach for early detection of multiple diseases by ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... The World Molecular Imaging Society ... Imaging.” The focus of ADDMI-IG will be geared towards how using molecular imaging ... Through ADDMI-IG WMIS will provide a platform for productive discussions about the implementation ...
(Date:5/25/2016)... ... May 25, 2016 , ... TransactRx announces the ... adjudication of medical service claims by Pharmacy Benefit Managers that were submitted by ... software. The TransactRx Cross Benefit Clearinghouse receives standard professional medical claims submitted from ...
(Date:5/25/2016)... ... 2016 , ... For more than fifty years, we've suffered whiplash as each new scientific study ... to the latest nutritional advice – advice that was supposed to keep us healthy and ... 3 American adults are considered to be overweight and more than 1 in 3 adults ...
(Date:5/25/2016)... ... , ... Consumer access to organic foods and grower access to food processers ... grain cereals and other plant-based foods, will introduce the first consumer product (a new ... by Hesco/Dakota Organic Products. , The transitional designation means the cereal was made using ...
(Date:5/24/2016)... ... , ... According to an article published May 11th on Fox ... the amount of calories they consumed by 25% experienced some interesting health benefits. This ... improved quality of life, and enhanced sexual function compared to the other group, which ...
Breaking Medicine News(10 mins):